Wädenswil/Zurich, Switzerland - Creoptix AG is pleased to announce that 1st PhileKorea Inc. will distribute Creoptix products and services in South Korea as exclusive channel partner.
“We’re delighted to welcome PhileKorea to the Creoptix family as an exclusive partner in the Korean market. With deep and longstanding customer relationships and an excellent reputation serving the local market, PhileKorea will be an asset to our brand,” says Line Stigen Raquet, Creoptix CEO.
PhileKorea provides research and diagnostic products and services to Korean research institutes, companies, universities and hospitals. The company specializes in supplying advanced overseas technologies as well as a wide range of own-brand products in the biotech field.
“1st PhileKorea is proud to be the exclusive Korean distributor of Creoptix products and services as part of our contribution to the scientific and pharmaceutical community,” adds Mr. Minbong Park, CEO of PhileKorea.
This new collaboration is another step forward in the Creoptix mission of enabling life scientists to accelerate discovery by providing cutting-edge tools for molecular interaction analysis.
